GlyNAC supplementation extends life span in mice
Glycine plus NAC is a winning combo, two separate inexpensive pills tested in humans and animals
Related Articles
Teamwork and a new nickname inspire patient through pancreatic cancer treatment – Mayo Clinic News Network
Dick Whetstone is working toward renewing his pilot’s license after pancreatic cancer nearly took away his passion. When Walter “Dick” […]
Mar 1 2024 This Week in Cardiology
The Western AF meeting, aspirin, cannabis use, LVEF in athletes, and shared decision making before ICD implantation are the topics John Mandrola, MD, discusses in…
Newsom Offers a Compromise to Protect Indoor Workers from Heat – KFF Health News
After rejecting proposed rules to protect millions of workers in sweltering warehouses, steamy kitchens, and other hot workplaces, California Gov. Gavin Newsom’s administration has offered…
Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
FDA Calls for Boxed Warnings for CAR T-Cell Immunotherapies
Following an investigation that began in November 2023, the FDA now requires boxed warnings regarding T-cell malignancies on all BCMA- and CD19-directed T-cell products.
Doctors underutilize next-gen antibiotics to fight resistant
NIH scientists find clinicians still rely often on older and toxic medicines.
Venomous Snakes Are Spreading because of Climate Change
Deadly bites could surge as venomous snakes migrate into unprepared countries as the climate changes
Heat-Related E.R. Visits Rose in 2023, C.D.C. Study Finds
As record heat enveloped the nation, the rate of emergency room visits increased compared with the previous five years, a sign of the major health…
DANTE and DANTE_LTR: computational pipelines implementing lineage-centered annotation of LTR-retrotransposons in plant genomes
Long terminal repeat (LTR) retrotransposons represent a predominant class of repetitive DNA elements in the genomes of most plant species. As the number of sequenced…
Barinthus’ HPV-related cancer therapy proves safety, but not efficacy
Barinthus Biotherapeutics has hit the primary endpoint of a phase 1b/2 trial by showing its treatment for high-risk human papillomavirus (hrHPV)-associated cervical cancer is safe.…
